Épisodes

  • The Alpha Edge: Perspective Therapeutics on the Future of Theranostics and Radiopharmaceutical Therapies

    The Alpha Edge: Perspective Therapeutics on the Future of Theranostics and Radiopharmaceutical Therapies
    Sep 9 2025
    In this episode of Tc for Biotech, host Chris Leidli sits down with Thijs Spoor, CEO of Perspective Therapeutics, to unpack the future of radiopharmaceuticals for the treatment of cancer. This conversation goes beyond the science to explore the infrastructure and strategy that determines success in bringing target cancer therapies to patients.
    Voir plus Voir moins
    37 min
  • Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment

    Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment
    Aug 21 2025
    In this episode of Rx for Biotech, host Chris Leidli sits down with Dr. Frank Bedu-Addo, CEO of PDS Biotechnology, to discuss how the company is reimagining immunotherapy with its proprietary Versamune® T-cell activating platform.
    Voir plus Voir moins
    40 min
  • How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield

    How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield
    Aug 5 2025
    Early cancer detection doesn't have to mean invasive tests. In this podcast episode, we sit down with Jeff Bousfield, CEO of Nonacus Cancer Diagnostics, to explore how his UK-based company is revolutionizing precision cancer diagnostics with a powerful suite of non-invasive tools. Jeff shares the human story behind the science and why he believes the future of cancer care starts with precision diagnostics tools that are faster, less invasive, and more accessible to patients.
    Voir plus Voir moins
    27 min
  • Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer

    Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer
    Jul 24 2025
    Metastatic pancreatic cancer remains one of the deadliest cancers, but a new approach is taking shape - and it's showing promise in early clinical studies. In this episode, Dan Schmitt, President and CEO of Actuate Therapeutics, shares how elraglusib, an investigational targeted therapy, may provide a new option for patients with metastatic pancreatic cancer. We explore the urgent unmet need and why Dan thinks this could be a turning point for one of oncology's toughest challenges.
    Voir plus Voir moins
    43 min
  • How Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly

    How Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly
    Jun 3 2025
    In this podcast episode, Dr. Kilian Kelly, CEO of Cynata Therapeutics, discusses the future of regenerative medicine! Discover how mesenchymal stem cells (MSCs)—powerful cells that repair and regenerate tissues—are revolutionizing treatments for a range of diseases. Dr. Kelly shares insights on Cynata’s groundbreaking Cymerus™ platform and the exciting potential of MSC therapies.
    Voir plus Voir moins
    29 min
  • Patient Perspective with CAR-T Cell Therapy Advocate, Brad Watt

    Patient Perspective with CAR-T Cell Therapy Advocate, Brad Watt
    May 8 2025
    Our guest in this podcast episode is lymphoma survivor and CAR-T cell therapy patient advocate, Brad Watts. In this episode, Brad shares his personal story battling lymphoma at the young age of 29 along with his experience receiving an innovative cell therapy. This field is transforming lives and Brad is living proof of this potential.
    Voir plus Voir moins
    38 min
  • How AI is Transforming Job Search and Recruiting in Life Sciences and Technology

    How AI is Transforming Job Search and Recruiting in Life Sciences and Technology
    Apr 24 2025
    AI is transforming job search, recruiting and hiring practices. Our guest in this podcast episode is Steve Swan, Practice Leader at The Swan Group. Steve is an Executive Recruiter specializing in technology for the Pharmaceutical and Biotech Industry. In this episode Steve shares his insights on how AI is transforming the hiring process.
    Voir plus Voir moins
    32 min
  • From Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere

    From Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere
    Mar 24 2025
    Gene therapy offers significant hope for treating sickle cell disease (SCD), a genetic disorder caused by a single mutation in the hemoglobin gene. Recent advancements have led to promising developments and FDA approvals, but challenges remain. In this podcast episode, gene therapy survivor, Jimi Olaghere, shares his journey and offers hope to others with his inspirational message and through his advocacy for patients in the sickle cell community.
    Voir plus Voir moins
    37 min